Role of calcium entry blockers in neurological diseases.
The current neurological indications for calcium entry blockers list a potential usefulness in tissue protection against the effects of cerebral anoxia and ischemia. Experimental data support these indications. Clinical data are preliminary so far and suggest designs for larger trials. A possible alternative strategy is the study of particular subgroups of patients such as the patients at excessive risk of stroke.